ScholarLens Back to search
2021•European Journal of PharmacologyRequires access

The role of CD44 in cancer chemoresistance: A concise review

Zohreh Yaghobi, Ali Akbar Movassaghpour, Mehdi Talebi, Mahdi Abdoli Shadbad, Khalil Hajiasgharzadeh, Shiva Pourvahdani, Behzad Baradaran

Open publisher page 112 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 112 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: CD44, Malignancy, Cancer research, Metastasis, Chemotherapy, Medicine, Cancer, Cell adhesion molecule

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
The role of CD44 in cancer chemoresistance: A concise review — Research Paper | ScholarLens